COMMUNIQUÉS West-GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
01/08/2025
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025
01/08/2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
01/08/2025
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly- [...]
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
01/08/2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
01/08/2025
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
01/08/2025
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non ‑ dilutive grant funding from [...]
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
01/08/2025
Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60 With two refills per year, Susvimo maintained [...]
Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m
01/08/2025
Press release August 1 st , 2025 Clariane has successfully completed a tap issue in the amount of 100 million euros of its notes due June 27, 2030, bringing its total amount to 500 million euros Paris, 1 st August 2025 [...]
Emission obligataire additionnelle de 100 M€ dans le cadre de l’emprunt obligataire venant à maturité le 27 juin 2030, portant le montant total à 500 M€
01/08/2025
Communiqué de presse Clariane place avec succès une émission obligataire additionnelle de 100 millions d’euros dans le cadre de l’emprunt obligataire venant à maturité le 27 juin 2030, portant le montant total à 500 [...]
Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors
01/08/2025
BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other [...]
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
01/08/2025
CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient [...]
IPG Health Introduces the Future of Market Research with ‘LivingMirror,’ an Always-On AI Focus Group for Healthcare
01/08/2025
Expanding network’s proprietary EPICC suite of tools for secure, AI-powered replicas of both HCPs and patients NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- For decades, market research has laid the foundation for deep [...]
Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives
01/08/2025
HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the [...]
Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma
01/08/2025
Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC [...]
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
01/08/2025
Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14 [...]
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
01/08/2025
Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone’s next phase of commercial execution ROSELAND, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Milestone [...]
Ocugen Provides Business Update with Second Quarter 2025 Financial Results
01/08/2025
Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for [...]
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
01/08/2025
WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]

Pages